PBS updates

Eligard 6 month (Leuprorelin)

leuprorelin acetate 45 mg modified release injection [1 syringe] (&) inert substance diluent [1 syringe], 1 pack · INJECTION · PBS code 13187C

RESTRICTED

What it costs

AU$1249.4 PBS-determined price per 1 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2022-12-01.
  • • Repeats: 0.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Central precocious puberty


Initial treatment


Must be treated by a paediatric endocrinologist; or

Must be treated by an endocrinologist specialising in paediatrics; AND

Patient must be of an age that is prior to their 10th birthday if female; or

Patient must be of an age that is prior to their 11th birthday if male; AND

Patient must have had onset of signs/symptoms of central precocious puberty prior to their 8th birthday if female; or

Patient must have had onset of signs/symptoms of central precocious puberty prior to their 9th birthday if male.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Central precocious puberty


Continuing treatment with this drug, or, switching gonadotropin releasing hormone analogue therapy


Must be treated by a medical practitioner identifying as one of: (i) a paediatric endocrinologist, (ii) an endocrinologist specialising in paediatrics; or

Must be treated by a medical practitioner who has consulted at least one of the above mentioned specialist types, with agreement reached that the patient should be treated with this pharmaceutical benefit on this occasion; AND

Patient must be undergoing continuing treatment with a gonadotropin releasing hormone analogue initiated through the PBS for this PBS indication.

Sponsor: Mundipharma Pty Limited ABN 87 081 322 509

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.